A Healthy Volunteer Trial Investigating MR-enterography Image Quality of Lumentin® 44
Status:
Completed
Trial end date:
2023-02-28
Target enrollment:
Participant gender:
Summary
A healthy volunteer, open, PoC single center trial investigating a new oral contrast agent
for use in combination of MR examination of the abdomen and pelvis.
The main purpose of the trial is to evaluate if Lumentin® 44 used as a bowel filling agent in
MRE examination generates images with acceptable diagnostic quality.
In addition, the plasma electrolytes concentration levels, including, potassium, sodium,
phosphate, and calcium, as well as ionized calcium will be evaluated over a 24 hour time
period after intake of Lumentin.